Hanmi Effort To Sell Nexium-Similar Drug Enjoined By U.S. Appeals Court
This article was originally published in PharmAsia News
Executive Summary
Hanmi Pharmaceutical's effort to sell its Esomezol (esomeprazole-tryhydrate) acid-reflux drug similar to AstraZeneca's Nexium (esomeprazole) has been put on hold by a U.S. court.